Striae Distensae (SD), represent linear dermal scars with epidermal atrophy of the epidermis that may cause significant cosmetic problems, especially in young women. Objectives:
To study the efficacy and safety of MnRF in the treatment of striae distensae. Materials and Methods:
A total of 20 patients (Male-7, Female-13) aged between 18-40 yrs with SD attending the dermatology OPD, received four sequential MnRF treatments with an interval of 4 weeks between each session. A detailed history, general physical and dermatological examination of the striae, along with photographs, of each patient was taken before and after the procedure with emphasis on striae distensae. Clinical assessment of improvement of striae was done based on Global Improvement Scale at their first visit & at the end of 1 month after the last session. In addition, patients were asked to provide their opinion on improvement of striae using the patient satisfaction score. Results:
Out of our 20 patients (n=20), subjected to 4 consecutive MnRF sessions, four weeks apart, 6 patients showed ‘marked improvement’, while 12 patients showed ‘moderate improvement’, and 2 had ‘minimal improvement’. According to the patient satisfaction score, 6 out of the twenty patients were ‘very satisfied’ with the treatment, while 8 were ‘satisfied’ and 6 were ‘slightly satisfied’ with their treatment outcome. No significant adverse effects were reported. Conclusion:
In our study, MnRF was found to be a safe and effective modality in the treatment of striae distensae.